Search For

Ovarian tumor microenvironment contributes to tumor progression and chemoresistance

Role of the TME in immune checkpoint blockade resistance of non-small cell lung cancer

Overcoming drug resistance through extracellular vesicle-based drug delivery system in cancer treatment

Reprogrammed lipid metabolism in advanced resistant cancers: an upcoming therapeutic opportunity

Current applications of tumor local ablation (TLA) combined with immune checkpoint inhibitors in breast cancer treatment

Current knowledge about immunotherapy resistance for melanoma and potential predictive and prognostic biomarkers

Mechanisms of tyrosine kinase inhibitor resistance in renal cell carcinoma

Emerging roles of 3D-culture systems in tackling tumor drug resistance

Unlocking antitumor immunity with adenosine receptor blockers

Drug resistance in glioblastoma: from chemo- to immunotherapy

Emerging resistance vs. losing response to immune check point inhibitors in renal cell carcinoma: two differing phenomena

Tumor-intrinsic metabolic reprogramming and how it drives resistance to anti-PD-1/PD-L1 treatment